Royal Bank of Canada’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Sell |
82
-4,372
| -98% | – | ﹤0.01% | 6901 |
|
2025
Q1 | $5K | Sell |
4,454
-23,692
| -84% | -$26.6K | ﹤0.01% | 5989 |
|
2024
Q4 | $62K | Buy |
28,146
+21,783
| +342% | +$48K | ﹤0.01% | 5110 |
|
2024
Q3 | $14K | Buy |
6,363
+647
| +11% | +$1.42K | ﹤0.01% | 5772 |
|
2024
Q2 | $13K | Sell |
5,716
-873
| -13% | -$1.99K | ﹤0.01% | 5864 |
|
2024
Q1 | $37K | Sell |
6,589
-45,183
| -87% | -$254K | ﹤0.01% | 5220 |
|
2023
Q4 | $128K | Buy |
51,772
+45,913
| +784% | +$114K | ﹤0.01% | 4938 |
|
2023
Q3 | $203K | Sell |
5,859
-6,694
| -53% | -$232K | ﹤0.01% | 4316 |
|
2023
Q2 | $411K | Buy |
12,553
+11,159
| +801% | +$365K | ﹤0.01% | 3705 |
|
2023
Q1 | $47K | Sell |
1,394
-1,989
| -59% | -$67.1K | ﹤0.01% | 5277 |
|
2022
Q4 | $111K | Sell |
3,383
-2,239
| -40% | -$73.5K | ﹤0.01% | 4908 |
|
2022
Q3 | $197K | Buy |
5,622
+5,495
| +4,327% | +$193K | ﹤0.01% | 4319 |
|
2022
Q2 | $2K | Sell |
127
-514
| -80% | -$8.09K | ﹤0.01% | 6539 |
|
2022
Q1 | $9K | Sell |
641
-1,440
| -69% | -$20.2K | ﹤0.01% | 6524 |
|
2021
Q4 | $41K | Buy |
+2,081
| New | +$41K | ﹤0.01% | 5956 |
|